It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.
According to The New England Journal of Medicine, investigators at Uppsala University Hospital implanted a product called ...
Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...
In 2025, innovative stem cell therapies are making significant strides towards a functional cure for Type-1 diabetes, potentially eliminating daily insulin injections.
Research is important to us for many reasons. Sometimes, for example, research results in a new treatment (e.g., Alexander ...
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...
The healthcare industry presents a wealth of opportunities for investors to generate notable portfolio returns over decades.
News-Medical.Net on MSN
Study overturns assumptions about PTPN22 risk gene’s role in interferon production
A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide ...
Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.
News Medical on MSN
Stem Cells: Cure for Type 1 Diabetes?
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells. While islet ...
Discover how precision biotherapeutics can transform healthcare in India by personalizing treatments based on genetic and molecular profiles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results